Search Tag: PET imaging
2025 02 Sep
Positron emission tomography (PET) is widely used in oncology and other areas of clinical practice for diagnosis, staging, treatment monitoring and follow-up. High-quality images are essential for detecting small lesions and guiding decisions, but image clarity is strongly linked to scan duration. While longer acquisitions improve image quality,...Read more
2025 17 Mar
Accurate staging plays a crucial role in the management of breast cancer, as it determines treatment plans and informs prognosis. Conventional staging methods primarily utilise 18F-FDG PET, which detects metabolic activity by measuring glucose uptake in cancerous tissues. However, this approach has limitations when applied to low-grade oestrogen...Read more
2025 24 Jan
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find CME On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/cmescience target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><aRead more
2024 09 May
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find CME On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/cmescience target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><aRead more
2018 25 Jul
Research on Alzheimer's disease is slowed down by the fact that most studies on the disease's effects on the brain are done postmortem. Now, there is a new noninvasive method for measuring a patient's synaptic loss, a critical component of the disease, which has the potential to accelerate research for new Alzheimer's treatments, according to a...Read more
2016 28 Nov
Positron emission tomography (PET) imaging can be useful in the diagnosis and prognosis in cardiac inflammatory disorders, including infective endocarditis, pericarditis and myocarditis, according to results of a systematic review published by The Quarterly Journal of Nuclear Medicine and Molecular Imaging. See Also : PACIFIC Trial: Comparing...Read more
2016 31 May
The effort to find ways to detect and diagnose preclinical Alzheimer’s disease (AD) has taken a big step forward with the use of positron emission tomography (PET), a “nuclear medicine” for imaging processes in the body, when PET is used with a special ‘tracer’ that binds to the amyloid plaques in the brain that are a characteristic cause of...Read more